✦ LIBER ✦

Are we missing the mTOR target in breast cancer?

✍ Scribed by Stephen R. D. Johnston

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 126 KB
Volume: 128
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-1207-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast boost: Are we missing the target?

Breast boost: Are we missing the target? : A dosimetric comparison of two boost techniques

✍ Rashmi K. Benda; Gopika Yasuda; Anil Sethi; Sheryl G.A. Gabram; Russell W. Hiner 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

## Abstract ## BACKGROUND Randomized trials have shown improved local control with the use of a breast boost for patients given breast‐conserving treatment for breast carcinoma. Although the use of a breast boost is routine practice, no standard technique has been established. The authors compared

The mTOR Pathway in Breast Cancer

✍ Nancy E. Hynes; Anne Boulay 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 242 KB

Are we missing 1 in 5 of colorectal canc

Are we missing 1 in 5 of colorectal cancers?

✍ Tine Jess 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

Breast cancer—have we been chasing the w

Breast cancer—have we been chasing the wrong target?

✍ William C. Dooley 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

What Are the Most Important New Targets

What Are the Most Important New Targets in Breast Cancer?

✍ Mary Cianfrocca 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 127 KB

Targeted therapy in prostate cancer—Are

Targeted therapy in prostate cancer—Are we our own worst enemy?

✍ Nancy A. Dawson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB